673 Shorter survival times following adjuvant endocrine therapy in oestrogen (ER) — and progesterone receptor (PgR) positive breast cancer (BC) overexpressing c-erbB-2 or with an increased expression of vascular endothelial growth factor (VEGF)

✍ Scribed by B. Linderholm; J. Andersson; E. von Schoultz; R. Fernstad; M. Linderholm; T. Hägerström; A.-L. Borg; L. Skoog; J. Bergh

• Book ID: 118620845
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 174 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90704-x